By webmin on
Phone
(877) 539-8515
Email
nspharma.expandedaccess@earlyaccesscare.com
ClinicalTrials.gov URL
https://clinicaltrials.gov/ct2/results?cond=&term=&spons=NS+Pharma&cntry=&state=&city=&dist=&Search=Search&recrs=a&recrs=b&recrs=d
Acknowledgement
Seven (7) business days
EA Page
https://www.earlyaccesscare.com/companies/ns+pharma+inc.
EA Therapies for Single Patient

Viltolarsen Expanded Access for Duchenne Muscular Dystrophy - Confirmed DMD mutation in the dystrophin gene that is amenable to skipping of exon 53

EA Policies for Single Patient

Single-Patient Expanded Access Policies and Criteria - If a treating physician believes that expanded access may be the only option for a patient, the physician should contact NS Pharma to make a formal request on behalf of a patient. Physicians may contact Early Access Care by emailing nspharma.expandedaccess@earlyaccesscare.com. We may request additional information to assist with patient eligibility for an investigational medication.

EA Policies for Disease / Category

https://www.earlyaccesscare.com/companies/ns+pharma+inc./viltolarsen